South Korea · Delayed Price · Currency is KRW Daewon Pharmaceutical Statistics
Total Valuation
KRX:003220 has a market cap or net worth of KRW 232.98 billion. The enterprise value is 367.20 billion.
| Market Cap | 232.98B |
| Enterprise Value | 367.20B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:003220 has 21.43 million shares outstanding. The number of shares has increased by 0.67% in one year.
| Current Share Class | 21.43M |
| Shares Outstanding | 21.43M |
| Shares Change (YoY) | +0.67% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.80% |
| Owned by Institutions (%) | 11.63% |
| Float | 12.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.30 |
| PS Ratio | 0.38 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | 18.62 |
| P/OCF Ratio | 5.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.15, with an EV/FCF ratio of 29.35.
| EV / Earnings | -266.15 |
| EV / Sales | 0.61 |
| EV / EBITDA | 13.15 |
| EV / EBIT | 88.09 |
| EV / FCF | 29.35 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.19 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 7.42 |
| Debt / FCF | 16.15 |
| Interest Coverage | 0.48 |
Financial Efficiency
Return on equity (ROE) is -0.79% and return on invested capital (ROIC) is -0.75%.
| Return on Equity (ROE) | -0.79% |
| Return on Assets (ROA) | 0.36% |
| Return on Invested Capital (ROIC) | -0.75% |
| Return on Capital Employed (ROCE) | 0.88% |
| Weighted Average Cost of Capital (WACC) | 1.60% |
| Revenue Per Employee | 471.89M |
| Profits Per Employee | -1.08M |
| Employee Count | 1,283 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 3.17 |
Taxes
In the past 12 months, KRX:003220 has paid 4.75 billion in taxes.
| Income Tax | 4.75B |
| Effective Tax Rate | 186.59% |
Stock Price Statistics
The stock price has decreased by -20.75% in the last 52 weeks. The beta is 0.26, so KRX:003220's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -20.75% |
| 50-Day Moving Average | 10,698.00 |
| 200-Day Moving Average | 12,186.35 |
| Relative Strength Index (RSI) | 54.67 |
| Average Volume (20 Days) | 30,002 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003220 had revenue of KRW 605.43 billion and -1.38 billion in losses. Loss per share was -87.38.
| Revenue | 605.43B |
| Gross Profit | 271.42B |
| Operating Income | 3.48B |
| Pretax Income | 2.55B |
| Net Income | -1.38B |
| EBITDA | 27.23B |
| EBIT | 3.48B |
| Loss Per Share | -87.38 |
Balance Sheet
The company has 76.48 billion in cash and 202.03 billion in debt, with a net cash position of -125.56 billion or -5,858.09 per share.
| Cash & Cash Equivalents | 76.48B |
| Total Debt | 202.03B |
| Net Cash | -125.56B |
| Net Cash Per Share | -5,858.09 |
| Equity (Book Value) | 274.58B |
| Book Value Per Share | 12,406.70 |
| Working Capital | 40.27B |
Cash Flow
In the last 12 months, operating cash flow was 42.31 billion and capital expenditures -29.80 billion, giving a free cash flow of 12.51 billion.
| Operating Cash Flow | 42.31B |
| Capital Expenditures | -29.80B |
| Depreciation & Amortization | 23.75B |
| Net Borrowing | 13.13B |
| Free Cash Flow | 12.51B |
| FCF Per Share | 583.77 |
Margins
Gross margin is 44.83%, with operating and profit margins of 0.58% and -0.23%.
| Gross Margin | 44.83% |
| Operating Margin | 0.58% |
| Pretax Margin | 0.42% |
| Profit Margin | -0.23% |
| EBITDA Margin | 4.50% |
| EBIT Margin | 0.58% |
| FCF Margin | 2.07% |
Dividends & Yields
This stock pays an annual dividend of 250.00, which amounts to a dividend yield of 2.29%.
| Dividend Per Share | 250.00 |
| Dividend Yield | 2.29% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.67% |
| Shareholder Yield | 1.61% |
| Earnings Yield | -0.59% |
| FCF Yield | 5.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Mar 7, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:003220 has an Altman Z-Score of 2.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.17 |
| Piotroski F-Score | 3 |